We are live on ! Find out more
PGM

Parian Global Management Portfolio holdings

AUM $30.8M
1-Year Est. Return 51.25%
This Fund
S&P 500
This Quarter Est. Return
-4.2%
1 Year Est. Return
-51.25%
3 Year Est. Return
+65.19%
5 Year Est. Return
10 Year Est. Return
AUM
$125M
AUM Growth
-$18.8M
Cap. Flow
-$7.78M
Cap. Flow %
-6.24%
Top 10 Hldgs %
68.67%
Holding
51
New
19
Increased
5
Reduced
8
Closed
18

Sector Composition

Rank Sector Weight
1 Healthcare 86.76%
2 Technology 1.93%
3 Communication Services 0%
4 Consumer Staples 0%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VAPO
1
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$28.4M 22.8%
171,399
+25,996
+18% +$4.5M
RNLX
2
DELISTED
Renalytix plc American Depositary Shares
RNLX
$9.14M 7.34%
574,706
+48,390
+9% +$969K
APEN
3
DELISTED
Apollo Endosurgery, Inc.
APEN
$8.36M 6.71%
991,229
+170,841
+21% +$1.49M
CELL
4
DELISTED
PhenomeX Inc. Common Stock
CELL
$7.3M 5.86%
401,487
+67,465
+20% +$1.46M
IRTC icon
5
iRhythm Holdings
IRTC
$3.54B
$6.41M 5.15%
54,466
-1,990
-4% -$183K
STIM icon
6
Neuronetics
STIM
$131M
$6.33M 5.08%
1,419,699
+548,080
+63% +$2.68M
PFE icon
7
PUT
Pfizer
PFE
$143B
$5.91M 4.74%
+100,000
New +$4.95M
CVRX icon
8
CVRx
CVRX
$130M
$4.76M 3.83%
389,536
-11,929
-3% -$173K
TOI icon
9
The Oncology Institute
TOI
$507M
$4.55M 3.65%
+466,676
New +$4.15M
ATEC icon
10
Alphatec Holdings
ATEC
$1.26B
$4.36M 3.5%
381,668
-226,306
-37% -$2.67M
STXS icon
11
Stereotaxis
STXS
$140M
$3M 2.41%
483,519
-183,686
-28% -$1.1M
IRTC icon
12
CALL
iRhythm Holdings
IRTC
$3.54B
$2.81M 2.26%
+23,900
New +$2.19M
QTRX icon
13
Quanterix
QTRX
$185M
$2.76M 2.21%
+65,010
New +$3.04M
SGRY icon
14
Surgery Partners
SGRY
$1.99B
$2.45M 1.96%
+45,797
New +$2.12M
USIO icon
15
Usio Inc
USIO
$52.2M
$2.4M 1.93%
551,013
-817,205
-60% -$4.92M
SERA icon
16
Sera Prognostics
SERA
$85M
$2.36M 1.89%
342,868
-731,030
-68% -$7.35M
ANGO icon
17
AngioDynamics
ANGO
$556M
$2.27M 1.83%
82,500
-39,162
-32% -$1.08M
CELL
18
CALL
DELISTED
PhenomeX Inc. Common Stock
CELL
$2.18M 1.75%
+120,000
New +$2.59M
AZTA icon
19
Azenta
AZTA
$1.3B
$2.11M 1.7%
+20,500
New +$2.22M
BDSX icon
20
Biodesix
BDSX
$231M
$2.1M 1.68%
19,811
-6,020
-23% -$786K
XRAY icon
21
Dentsply Sirona
XRAY
$2.55B
$2.1M 1.68%
+37,578
New +$2.07M
BLFS icon
22
BioLife Solutions
BLFS
$1.5B
$2.05M 1.65%
+55,100
New +$2.36M
PODD icon
23
Insulet
PODD
$11B
$1.68M 1.35%
+6,300
New +$1.83M
LHDX
24
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$1.58M 1.27%
+183,804
New +$1.17M
VAPO
25
CALL
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$1.55M 1.25%
+9,375
New +$1.62M

Similar funds

Parian Global Management's Q4 2021 Portfolio in Review

As of Q4 2021, Parian Global Management held 51 positions worth $125M, down 13% from $143M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Parian Global Management withdrew a net $7.78M in Q4 2021, closing 18 positions and reducing 8 holdings. Its most notable exit was CareMax, Inc. Class A Common Stock, an estimated $5.74M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 85% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Parian Global Management opened a new position in The Oncology Institute worth $4.55M.

  • Parian Global Management's largest Q4 2021 buy was The Oncology Institute: 466,676 shares worth $4.55M.
  • Parian Global Management added most to Vapotherm, Inc. Common Stock in Q4 2021, an estimated $4.5M increase.
  • Parian Global Management's biggest Q4 2021 reduction was Sera Prognostics, cutting an estimated $7.35M.
  • Parian Global Management fully exited CareMax, Inc. Class A Common Stock in Q4 2021, selling an estimated $5.74M.
  • Parian Global Management's ten largest holdings make up 69% of its $125M portfolio in Q4 2021.
  • Parian Global Management opened 19 new positions and closed 18 in Q4 2021.
  • Parian Global Management's portfolio value fell 13% quarter-over-quarter to $125M.

Based on Parian Global Management's 13F filing for Q4 2021, filed 14 Feb 2022.